Alnylam Pharmace. buy Biotechhunter
Start price
26.06.20
/
50%
€139.00
Target price
31.07.20
-
Performance (%)
-9.70%
End price
31.07.20
€125.52
Summary
This prediction ended on 31.07.20 with a price of €125.52. With a performance of -9.70%, the BUY prediction for Alnylam Pharmace. by Biotechhunter closed slightly in the red. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -1.894% | -1.894% | 15.233% | 51.038% |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.